Mitali Chattopadhyay Selected Research

nitroxy-butyl-acetylsalicylic acid

7/2015	Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
12/2010	NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.
6/2010	Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells.
11/2009	Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitali Chattopadhyay Research Topics

Disease

15	Neoplasms (Cancer) 01/2020 - 12/2011
9	Colonic Neoplasms (Colon Cancer) 12/2015 - 06/2010
3	Stomach Ulcer (Gastric Ulcer) 12/2015 - 04/2013
3	Hyperalgesia 12/2015 - 11/2010
3	Breast Neoplasms (Breast Cancer) 07/2015 - 11/2009
3	Leukemia 03/2012 - 06/2010
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 01/2019
2	Hemorrhage 12/2015 - 12/2015
2	Edema (Dropsy) 01/2013 - 03/2012
2	Carcinogenesis 03/2012 - 11/2010
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2010 - 06/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2015
1	Ulcer 04/2013
1	Triple Negative Breast Neoplasms 03/2012
1	Adenocarcinoma 03/2012
1	Fever (Fevers) 11/2010
1	Inflammation (Inflammations) 11/2010
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2010

Drug/Important Bio-Agent (IBA)

12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 11/2009
9	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2015 - 03/2012
6	4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoateIBA 01/2020 - 03/2012
5	CarrageenanIBA 12/2015 - 11/2010
4	Analgesics (Analgesic Drugs)IBA 01/2016 - 11/2010
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2015 - 03/2012
4	nitroxy-butyl-acetylsalicylic acidIBA 07/2015 - 11/2009
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015 - 11/2010
4	Naproxen (Naprosyn)FDA LinkGeneric 01/2015 - 12/2010
4	4-(5-thioxo-5H-1,2-dithiol-3-yl)-phenyl 2-acetoxybenzoateIBA 10/2013 - 03/2012
3	AntipyreticsIBA 01/2016 - 11/2010
3	Dinoprostone (PGE2)FDA Link 12/2015 - 04/2013
3	Sulindac (Copal)FDA LinkGeneric 12/2015 - 03/2012
3	nitroaspirinIBA 07/2015 - 11/2009
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	GlucocorticoidsIBA 01/2020 - 01/2019
2	Hormones (Hormone)IBA 01/2019 - 03/2012
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2015 - 04/2013
2	EnzymesIBA 12/2015 - 03/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015 - 07/2015
2	Estrogen ReceptorsIBA 07/2015 - 03/2012
2	CarcinogensIBA 03/2012 - 06/2010
2	ProdrugsIBA 12/2010 - 11/2010
2	beta CateninIBA 06/2010 - 11/2009
1	Caspase 3 (Caspase-3)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	CytokinesIBA 01/2019
1	Benzoates (Benzoate)IBA 10/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	2-(6-methoxy-naphthalen-2-yl)-propionic acid 4-(5-thioxo-5H-(1,2)dithiol-3-yl)-phenyl esterIBA 01/2015
1	Superoxide DismutaseIBA 04/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013
1	Malondialdehyde (Propanedial)IBA 04/2013
1	Estrogens (Estrogen)FDA Link 03/2012
1	XenobioticsIBA 03/2012
1	Phosphates (Orthophosphate)IBA 12/2011
1	quinone methideIBA 12/2011
1	naproxen-n-butyl nitrateIBA 12/2010
1	CateninsIBA 12/2010
1	Proteins (Proteins, Gene)FDA Link 06/2010
1	CaspasesIBA 06/2010

Therapy/Procedure

2	Therapeutics 01/2020 - 03/2012